Vineeta Belanger
Chief Tech/Sci/R&D Officer chez LYRA THERAPEUTICS, INC.
Profil
Dr. Vineeta Belanger is a Senior Vice President-Clinical Affairs at Lyra Therapeutics, Inc. Dr. Belanger was previously employed as a Vice President-Clinical Affairs by Avedro, Inc. and a Principal by Ironwood Pharmaceuticals, Inc. She received her undergraduate degree from All India Institute of Medical Sciences and a doctorate degree from the University of Houston.
Postes actifs de Vineeta Belanger
| Sociétés | Poste | Début |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2019 |
Anciens postes connus de Vineeta Belanger
| Sociétés | Poste | Fin |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| AVEDRO, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Vineeta Belanger
| University of Houston | Doctorate Degree |
| All India Institute of Medical Sciences | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| LYRA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Avedro, Inc.
 Avedro, Inc. Medical SpecialtiesHealth Technology Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm’s products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA. | Health Technology |
